Specialized single-cell "cores" are popping up to help scientists get the most out of new technologies.
The single-cell VDJ profiling kit is the first of a suite of immunology products the company plans to launch this year.
In Science this week: sequencing study of IDH glioma origins, and more.
The researchers used SC3 to uncover subclones within samples from patients with pre-malignant tumors.
In Nature this week: genotypes linked to hip osteoarthritis, and more.
In Genome Biology this week: genes linked to Hirschsprung disease, structural variant patterns in autism, and more.
Mutation and expression patterns in longitudinal, multifocal, and solitary tumor samples suggest glioblastoma follows a multiverse model of evolution.
In PNAS this week: diatom genetic diversity, microfluidic droplet method for single-cell screening, and more.
The platform, called Seq-Well, is similar to droplet-based approaches but reports increased efficiency.
The firm's full-year 2016 revenues fell 9 percent, also on lower instrument sales.
The Chan Zuckerberg Initiative is investing in Cold Spring Harbor Laboratory's BioRxiv.
A study appearing in PLOS One finds that shortened consent forms don't affect clinical trial participants' understanding of the study.
The National Security Agency monitored signal intelligence for signs of "nefarious" genetic engineering projects, Gizmodo reports.
In Nature this week: barley genome sequenced, method for genotyping and phasing short tandem repeats, and more.